Patents by Inventor Caroline Delattre

Caroline Delattre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10351838
    Abstract: The subject matter of the present invention is in particular the use of an amino acid sequence of IDE, or of an analogue or fragment thereof, or of at least one nucleic acid sequence encoding this sequence, as a biomarker, or as an active agent, with regard to a dandruff condition of the scalp.
    Type: Grant
    Filed: December 12, 2011
    Date of Patent: July 16, 2019
    Assignee: L'OREAL
    Inventors: Caroline Delattre, Philemon Sirven, Dominique Bernard
  • Patent number: 9168215
    Abstract: The present invention is directed to the use, in particular cosmetic use, of an effective amount of at least one lacritin-type polypeptide, of an analogue thereof or of a fragment thereof, of at least one nucleic acid sequence encoding this polypeptide, or of at least one agent that modulates the activity, the stability or the expression of this polypeptide, or its interaction with syndecan-1, as an agent useful for the care of the skin and of appendages thereof.
    Type: Grant
    Filed: July 16, 2010
    Date of Patent: October 27, 2015
    Assignee: L'OREAL
    Inventors: Caroline Delattre, Dominique Bernard, Mark Donovan
  • Publication number: 20130337085
    Abstract: The subject matter of the present invention is in particular the use of an amino acid sequence of IDE, or of an analogue or fragment thereof, or of at least one nucleic acid sequence encoding this sequence, as a biomarker, or as an active agent, with regard to a dandruff condition of the scalp.
    Type: Application
    Filed: December 12, 2011
    Publication date: December 19, 2013
    Applicant: L'oreal
    Inventors: Caroline Delattre, Philemon Sirven, Dominique Bernard
  • Publication number: 20130324476
    Abstract: The present invention relates, in particular, to the use of a sequence of amino acids of dermicidin or an analogue or fragment thereof, and at least one sequence of nucleic acids coding said sequence as a biomarker for ageing skin and/or the signs of skin ageing which are possibly associated with skin dryness.
    Type: Application
    Filed: September 23, 2011
    Publication date: December 5, 2013
    Applicant: L'OREAL
    Inventors: Caroline Delattre, Audrey Gueniche, Isabelle Castiel, Dominique Bernard
  • Publication number: 20120190627
    Abstract: The present invention is directed to the use, in particular cosmetic use, of an effective amount of at least one lacritin-type polypeptide, of an analogue thereof or of a fragment thereof, of at least one nucleic acid sequence encoding this polypeptide, or of at least one agent that modulates the activity, the stability or the expression of this polypeptide, or its interaction with syndecan-1, as an agent useful for the care of the skin and of appendages thereof.
    Type: Application
    Filed: July 16, 2010
    Publication date: July 26, 2012
    Applicant: L'OREAL
    Inventors: Caroline Delattre, Dominique Bernard, Mark Donovan
  • Publication number: 20040197299
    Abstract: Hydrolase polypeptides having amidase activity and products capable of modulating the activity thereof are well suited for the treatment of, inter alia, dry skins and/or the signs of skin aging and/or for combating skin desquamation.
    Type: Application
    Filed: January 15, 2004
    Publication date: October 7, 2004
    Applicant: SOCIETE L'OREAL, S.A.
    Inventors: Caroline Delattre, Dominique Bernard, Bruno Mehul